S K Carter. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Adenocarcinoma/drug therapyAnimalsBreast Neoplasms/drug therapyCarcinoma, Bronchogenic/drug therapyDoxorubicin/administration & dosageDoxorubicin/adverse effectsDoxorubicin/analogs & derivativesDoxorubicin/metabolismDoxorubicin/pharmacologyDoxorubicin/therapeutic useDrug EvaluationDrug Evaluation, PreclinicalDrug Therapy, CombinationHeart Failure/chemically inducedHodgkin Disease/drug therapyHumansImmunity/drug effectsLeukemia, Lymphoid/drug therapyLymphoma, Large B-Cell, Diffuse/drug therapyLymphoma, Non-Hodgkin/drug therapyMiceMice, Inbred StrainsMitosis/drug effectsNeoplasm Metastasis/drug therapyNeoplasms/drug therapyNeoplasms, Experimental/drug therapyNeuroblastoma/drug therapyOsteosarcoma/drug therapySarcoma/drug therapyThyroid Neoplasms/drug therapyUrinary Bladder Neoplasms/drug therapy
Substances: See more » Doxorubicin
Year: 1975 PMID: 1107570 DOI: 10.1093/jnci/55.6.1265
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506